Dr Peter Harper

Dr Peter Harper

FRCP, MRCS

Consultant Medical Oncologist

I trained at University College and University College Hospital (MB BS 1970) and have been a leading consultant at Guy’s and St Thomas Hospital for over 25 years. I am both an accredited physician and a medical oncologist. One of the four founder partners of the London Oncology Clinic, my vision was of a clinic dedicated solely to cancer treatment offering the highest international standards of care in a state-of-the-art supportive environment, also providing the support including all the ancillary care required by patients and their families.

Author of more than 400 papers and chapters in peer reviewed publications, I am acknowledged globally for my work in researching new drugs and developing improved forms of cancer treatment. I have been the chair, or have been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications and am currently a member of eight pharmaceutical company advisory boards and am a member of sixteen professional bodies form around the world, including board membership of a committee of the American Society of Clinical Oncologists (ASCO).

In 2002 I was awarded the prestigious Cino del Duca Medal in 2004 in recognition of my work in developing new anti-cancer and vaccine therapies. For my role in advising the French Government in strategic cancer care (Board Member French National Cancer Institute) I was appointed a Chevalier of the Legion D’Honneur, a rare distinction for a foreign national. I remain on the board of INCA, the strategic committee for cancer treatment in France, and am currently the Chairman of the Toulouse Cancer Centre and hold the Medaille D’Or of that city.

NHS Trust

  • Emeritus Consultant at Guy’s and St Thomas’ NHS Foundation Trust.

Research and Publications

Author of more than 400 papers and chapters in peer reviewed publications, he is acknowledged globally for his work in researching new drugs and developing improved forms of cancer treatment. He has been the chair, or has been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications and is currently a member of eight pharmaceutical company advisory boards and is a member of sixteen professional bodies form around the world, including board membership of a committee of the American Society of Clinical Oncologists (ASCO).

LOC 95 Harley Street
LOC at Chelsea